Sanofi Consumer Healthcare

Sanofi Consumer Healthcare

4,683.70
-31.50
(-0.67%)
hide
Key Fundamentals
Add Ratio
Market Cap
10,859.40 Cr
EPS
78.59
PE Ratio
53.90
Dividend Yield
1.17 %
Industry
Healthcare
52 Week High
5,894.50
52 Week Low
4,537.45
PB Ratio
41.94
Debt to Equity
0.04
Analyst Rating and Forecast
- By Refinitiv from1 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+100.00 %
+100.00 %
Hold
Hold0.0 %
0.0 %
Sell
Sell0.0 %
0.0 %
Forecast For
Actual

Company News

View All News
Caret
positive
Sanofi Consumer Healthcare India Limited appointed Richard D'souza as Chief Financial Officer effective October 16, 2025. The appointment was approved by the Board of Directors based on recommendations from the Nomination and Remuneration Committee and in consultation with the Audit Committee. D'souza brings over 25 years of leadership experience in finance across multinational and listed organizations in FMCG and consumer goods sectors. He has expertise in financial strategy, M&A, investor relations, governance, and digital transformation. Previously, he served as Head of Finance at Bajaj Consumer Care, where he led acquisitions and strategic market expansion. He also worked with Castrol India managing treasury operations and ERP migrations. D'souza is a Chartered Accountant and Certified Information Systems Auditor.
neutral
Sanofi Consumer Healthcare India Limited announced that Chief Financial Officer Narahari Naidu has resigned from his position to explore new career opportunities outside the organization. His resignation becomes effective from the close of business hours on October 15, 2025, which will be his last working day with the company. In his resignation email, Naidu expressed gratitude for the trust and support from the Board, senior leadership team, and colleagues during his tenure.
positive
Sanofi Consumer Healthcare India Limited appointed Mr. Narahari Naidu as Chief Financial Officer effective August 4th, 2025, for a six-month term. The appointment was approved by the Board of Directors based on recommendations from the Nomination and Remuneration Committee and in consultation with the Audit Committee. Naidu brings over 14 years of experience across healthcare/pharmaceuticals, manufacturing, and consulting sectors, with expertise in Finance & Accounts, Procurement, Investor Relations, Mergers & Acquisitions, Banking & Treasury, and IPO management. He previously served as Group CFO for entities operating across India, UK and USA.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,679.10
#1 3,98,049.70
38.75
#1 54,729.00
9.71
#1 10,980
-19.84
61.71
6,621.50
1,75,222.50
76.19
9,712.00
18.67
2,191
26.74
72.60
1,577.60
1,26,768.90
23.67
28,409.50
7.12
5,291
9.88
60.63
3,584.30
1,19,599.80
60.49
11,539.40
6.99
1,911
19.91
53.74
1,255.90
1,03,508.80
#1 18.25
33,741.20
16.73
5,725
1.26
48.97
2,476.60
1,01,344.60
53.48
12,744.20
#1 20.90
2,007
-18.14
47.04
987.65
99,073.80
21.09
23,511.00
18.55
4,615
2.60
45.37
1,940.00
89,121.90
23.79
22,909.50
13.74
3,306
#1 51.64
46.82
5,581.50
66,047.70
28.61
13,458.30
3.70
2,216
21.39
63.11
1,101.00
64,254.10
19.04
32,345.60
9.43
3,484
-10.24
50.87
Growth Rate
Revenue Growth
31.81 %
Net Income Growth
9.76 %
Cash Flow Change
1,09,850.00 %
ROE
-16.53 %
ROCE
-18.07 %
EBITDA Margin (Avg.)
-

Yearly Financial Results

Annual Financials
2023
2024
TTM
Revenue
560
738
751
Expenses
337
454
469
EBITDA
223
284
282
Operating Profit %
39 %
37 %
36 %
Depreciation
2
5
8
Interest
0
4
5
Profit Before Tax
219
247
270
Tax
54
66
70
Net Profit
165
181
200
EPS in ₹
71.60
78.59
86.80

Balance Sheet

Balance Sheet
2023
2024
Total Assets
345
431
Fixed Assets
5
29
Current Assets
335
392
Capital Work in Progress
3
1
Investments
0
0
Other Assets
338
402
Total Liabilities
345
431
Current Liabilities
130
131
Non Current Liabilities
8
28
Total Equity
208
273
Reserve & Surplus
183
250
Share Capital
2
23

Cash Flow

Cash Flow
2023
2024
Net Cash Flow
2
325
Investing Activities
0
2
Operating Activities
-0
439
Financing Activities
2
-116

Share Holding

% Holding
Jun 2024
Sept 2024
Oct 2024
Dec 2024
Mar 2025
Jun 2025
Promoter
60.40 %
60.40 %
60.40 %
60.40 %
60.40 %
71.27 %
FIIs
0.00 %
5.22 %
4.87 %
4.42 %
4.53 %
3.24 %
DIIs
20.87 %
24.03 %
24.51 %
25.35 %
25.48 %
16.89 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
7.71 %
7.53 %
7.41 %
7.01 %
6.58 %
6.30 %
Others
11.03 %
2.83 %
2.82 %
2.83 %
3.01 %
2.30 %
No of Share Holders
61,091
61,091
57,598
55,734
51,859
49,632

Dividend History

Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 55 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.14 0.00

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
12 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 Nov 2024 4,864.05 4,911.45
20 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
20 Feb 2025 4,714.65 4,743.70
17 Apr 2025 DIVIDEND Dividend
₹ 55.00 /share
17 Apr 2025 4,743.70 4,984.00
02 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
02 May 2025 4,940.10 4,942.35
05 May 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
05 May 2025 4,750.15 4,938.45
04 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
04 Aug 2025 4,968.40 4,864.10

Announcements

Announcement under Regulation 30 (LODR)-Change in Management1 day ago
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 20188 days ago
Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)8 days ago
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 30, 2025
Shareholder Meeting / Postal Ballot-Notice of Postal BallotSep 29, 2025
Closure of Trading WindowSep 27, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementSep 01, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 06, 2025
Appointment Of Chief Financial Officer - Key Managerial PersonnelAug 04, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 04, 2025
Outcome Of Board Meeting Held On Monday 4Th August 2025Aug 04, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On Monday 4Th August 2025Aug 04, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On Monday 4Th August 2025Aug 04, 2025
Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results For The Quarter And Half Year Ended 30Th June 2025Jul 29, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 14, 2025
Closure of Trading WindowJun 26, 2025
Disclosure Under Securities And Exchange Board Of India (Prohibition Of Insider Trading) Regulations 2015Jun 13, 2025
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Jun 13, 2025
Post-Offer AdvertisementMay 24, 2025
Updates on Open OfferMay 10, 2025
Updates on Open OfferMay 09, 2025
Updates on Open OfferMay 08, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportMay 07, 2025
Updates on Open OfferMay 07, 2025
Updates on Open OfferMay 06, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMMay 05, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 03, 2025
Updates on Open OfferMay 03, 2025
Updates on Open OfferMay 03, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 02, 2025
Board Meeting Outcome For Consideration And Approval Of Unaudited Financial Results For The Quarter Ended 31St March 2025May 02, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Held On Friday 2Nd May 2025May 02, 2025
Updates on Open OfferMay 02, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 01, 2025
Updates on Open OfferApr 30, 2025
Board Meeting Intimation for Board Meeting Intimation For Consideration And Approval Of Unaudited Financial Results For The Quarter Ended 31St March 2025Apr 25, 2025
Updates on Open OfferApr 24, 2025
Corrigendum To The Annual Report For Financial Year 2024Apr 23, 2025
Reg. 34 (1) Annual Report.Apr 23, 2025
Letter of OfferApr 16, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 15, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationApr 13, 2025
Business Responsibility and Sustainability Reporting (BRSR)Apr 12, 2025
Shareholder Meeting - AGM On May 5 2025Apr 12, 2025
Reg. 34 (1) Annual Report.Apr 12, 2025
Newspaper Publication Of Recommendations By The Committee Of Independent Directors Pursuant To Regulation 26(7) Of The SEBI (SAST) Regulations 2011 Is Enclosed.Apr 11, 2025
Announcement under Regulation 30 (LODR)-Open Offer - UpdatesApr 10, 2025
Intimation For Change In Record Date For DividendApr 09, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementApr 04, 2025
Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)Apr 04, 2025

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Nippon India Multi Asset Allocation Fund Direct - Growth
0.46%
47765
0.25%
0.25%
ICICI Prudential Smallcap Fund Direct Plan-Growth
1.18%
11240
-0.05%
0.00%
ICICI Prudential Children's Fund Direct-Growth
0.34%
10000
0.34%
0.34%
Motilal Oswal Nifty Microcap 250 Index Fund Direct - Growth
0.41%
-9027
-0.23%
-0.17%
Aditya Birla Sun Life Large Cap Direct Fund-Growth
0.49%
6288
-0.04%
0.00%
UTI Dividend Yield Fund Direct-Growth
0.51%
2732
-0.02%
0.05%
Bajaj Finserv Flexi Cap Fund Direct-Growth
0.89%
1500
-0.11%
-0.06%
Bajaj Finserv Healthcare Fund Direct-Growth
2.03%
1200
0.05%
0.21%
Bajaj Finserv Multi Asset Allocation Fund Direct-Growth
0.81%
659
-0.08%
-0.02%
Bajaj Finserv Equity Savings Fund Direct-Growth
0.30%
200
0.30%
0.30%
Groww Nifty Total Market Index Fund Direct - Growth
0.02%
-42
-0.01%
-0.01%
Bandhan BSE Healthcare Index Fund Direct-Growth
0.24%
-35
-0.11%
-0.09%
Mirae Asset Nifty Total Market Index Fund Direct-Growth
0.01%
-6
-0.01%
-0.01%
Angel One Nifty Total Market Index Fund Direct - Growth
0.02%
-6
-0.01%
-0.01%
Bandhan Nifty Total Market Index Fund Direct-Growth
0.02%
-6
0.00%
0.00%
Aditya Birla Sun Life Dividend Yield Fund Direct-Growth
0.63%
0
-0.07%
-0.02%
Aditya Birla Sun Life Small Cap Fund Direct-Growth
1.11%
0
-0.12%
-0.01%
Bajaj Finserv Balanced Advantage Fund Direct-Growth
1.37%
0
-0.14%
-0.04%
Baroda BNP Paribas Midcap Fund Direct-Growth
0.93%
0
-0.11%
-0.03%
Baroda BNP Paribas Small Cap Fund Direct - Growth
0.99%
0
-0.09%
0.00%
Baroda BNP Paribas Value Fund Direct - Growth
1.01%
0
-0.09%
0.00%
Nippon India Small Cap Fund Direct- Growth
0.17%
0
-0.02%
0.00%
ICICI Prudential Bharat Consumption Fund Direct - Growth
0.52%
0
-0.04%
-0.02%
Aditya Birla Sun Life Pharma & Healthcare Fund Direct-Growth
1.09%
0
-0.09%
0.04%
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct - Growth
0.80%
0
-0.09%
-0.05%

Technical Indicators

RSI(14)
Neutral
37.42
ATR(14)
Less Volatile
137.73
STOCH(9,6)
Neutral
35.84
STOCH RSI(14)
Overbought
89.22
MACD(12,26)
Bearish
-1.87
ADX(14)
Strong Trend
33.86
UO(9)
Bearish
42.17
ROC(12)
Downtrend And Accelerating
-0.78
WillR(14)
Neutral
-71.17